Literature DB >> 32550773

Comparing Colored and White-Black Visual Evoked Potentials in Multiple Sclerosis Patients.

Erkan Acar1, Aysun Soysal1, Mesude Tütüncü1, Zeynep Özdemir1, Selin Kaya2, Nilüfer Kale1.   

Abstract

INTRODUCTION: We compared white-black (WB), white-red (WR), and black-red (BR) checkerboard stimulated visual evoked potentials (VEPs) in multiple sclerosis (MS) patients and aimed to evaluate if redcolored VEP is more sensitive than WB VEP for the diagnosis of optic neuritis (ON).
METHODS: Twenty-nine MS patients (21 females [72.4%]) and 35 healthy control subjects (24 females [68.6%]) were included in the study. Neurological and ophthalmological examinations were conducted for all subjects and VEP and optical coherence tomography (OCT) investigations were performed.
RESULTS: A significant difference was found between MS patients and the control group for WB, WR, BR stimulated VEP P100 latencies and retinal nerve fiber length (RNFL) and ganglion cell complex (GCC) thicknesses, but there was no difference for WB, WR, and rb stimulated VEP amplitude values between the groups. There was no significant pathological difference between the eyes with an ON history in MS and eyes without an ON history in MS and control subjects after WB, WR, and BR stimulation (p=).
CONCLUSIONS: The WB checkerboard stimulated VEP is an ample test for routine use; further studies are necessary regarding the utility of rb stimulated VEP in detecting subclinical ON. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Multiple sclerosis; colored visual evoked potentials; optic neuritis; optical coherans tomography

Year:  2017        PMID: 32550773      PMCID: PMC7285632          DOI: 10.5152/npa.2017.22787

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  16 in total

1.  Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.

Authors:  M J Thurtell; E Bala; S S Yaniglos; J C Rucker; N S Peachey; R J Leigh
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

2.  Comparison of fiber optical and video monitor stimulators in normals and multiple sclerosis patients.

Authors:  Y Hod; H Pratt; S E Schacham
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-11

3.  Coloured pattern displacement and VEP amplitude.

Authors:  N O Parry-Jones; P Fenwick
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-01

4.  Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey.

Authors:  T L Sørensen; J L Frederiksen; H Brønnum-Hansen; H C Petersen
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

5.  Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.

Authors:  Niphon Chirapapaisan; Sawarin Laotaweerungsawat; Wanicha Chuenkongkaew; Patthanee Samsen; Ngamkae Ruangvaravate; Atiporn Thuangtong; Nacha Chanvarapha
Journal:  Doc Ophthalmol       Date:  2014-10-21       Impact factor: 2.379

6.  Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.

Authors:  Elke Voss; Peter Raab; Corinna Trebst; Martin Stangel
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

7.  A new color vep procedure discloses asymptomatic visual impairments in optic neuritis and glaucoma suspects.

Authors:  N Accornero; B Gregori; E Galié; A De Feo; R Agnesi
Journal:  Acta Neurol Scand       Date:  2000-10       Impact factor: 3.209

8.  Chromatic modulation of luminance visual evoked potential latencies in healthy subjects and patients with mild vision disorders.

Authors:  N Accornero; B Gregori; S Pro; G Scappini; M La Riccia
Journal:  Clin Neurophysiol       Date:  2008-05-01       Impact factor: 3.708

9.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Authors: 
Journal:  Arch Neurol       Date:  2008-06

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.